Atypical squamous cells and low squamous intraepithelial lesions in postmenopausal women: Implications for management

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 140, Issue 2, 2008, Pages 269-274

  Piccoli, Roberto ^a   Mandato, Vincenzo D ^a   Lavitola, Giada ^a   Acunzo, Giuseppe ^a   Bifulco, Giuseppe ^a   Tommaselli, Giovanni A ^a   Attianese, Wanda ^a   Nappi, Carmine ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

ASCUS; ERT; LSIL; Menopause

Indexed keywords

PROMESTRIENE; VIRUS DNA;

ADULT; ARTICLE; CANCER PATIENT; CANCER SURGERY; COLPOSCOPY; CURETTAGE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ESTROGEN DEFICIENCY; ESTROGEN THERAPY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MENOPAUSAL SYNDROME; MENOPAUSE; POSTMENOPAUSE; PRECANCER; PRIORITY JOURNAL; PUNCH BIOPSY; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CONIZATION; UTERINE CERVIX CYTOLOGY; VIRUS DETECTION; WART VIRUS;

EID: 52949114918     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2008.05.007     Document Type: Article

References (30)

1. Solomon D., Davey D., Kurman R., et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 287 (2002) 2114-2119
2. National Cancer Institute Workshop. The 1988 Bethesda System for reporting cervical/vaginal cytologic diagnoses. JAMA 262 (1989) 931-934
3. Kurman R., Henson D., Herbst A., Noller K.L., and Schiffman M.H. Interim guidelines for management of abnormal cervical cytology. JAMA 271 (1994) 1866-1869
4. Kurman R., and Solomon D. The Bethesda System for reporting cervical/vaginal cytologic diagnoses: definitions, criteria and explanatory notes for terminology and specimen adequacy (1994), Springer Verlag, New York
5. Prendiville W., Ritter J., Tatti S., and Twiggs L. Management del Pap test anormale. Linee guida della SICPCV. Colposcopy: management options (2005), Elsevier Italia p. 205
6. Prendiville W., Ritter J., Tatti S., and Twiggs L. Anatomia ed istopatologia delle neoplasie intraepiteliali del tratto genitale inferiore. Colposcopy: management options (2005), Elsevier Italia p. 12
7. Munoz N. Human papillomavirus and cancer: the epidemiological evidence. J Clin Virol 19 (2000) 1-5
8. Walboomers J.M.M., Jacobs M.W., Manos M.M., et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189 (1999) 12-19
9. Cibas E.S., Browne T.J., Bassichis M.H., and Lee K.R. Enlarged squamous cell nuclei in cervical cytologic specimens from perimenopausal women (PM Cells): a cause of ASC overdiagnosis. Am J Clin Pathol 124 (2005) 58-61
10. Fidda N., Miron J., Rodgers W.H., and Rader A. Impact of the new Bethesda System 2001 on specimen adequacy of conventional cervicovaginal smears. Diagn Cytopathol 30 (2004) 235-239
11. Sellors J.W., Karwalajtys T.A., Kaczorowski J.A., et al. Prevalence of infection with carcinogenic human papillomavirus among older women. Can Med Assoc J 167 (2002) 871-873
12. Herrero R., Hildesheim A., Bratti C., et al. Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica. J Natl Cancer Inst 92 (2000) 464-474
13. ASCUS LSIL Triage Study Group. Predicting absolute risk of CIN3 during post-colposcopic follow-up: results from the ASCUS-LSIL Triage Study (ALTS). Am J Obstet Gynecol 195 (2006) 341-348
14. Wright Jr. T.C., Cox J.T., Massad L.S., Twiggs L.B., and Wilkinson E.J. ASCCP-Sponsored Consensus Conference. 2001 Consensus Guidelines for the management of women with cervical cytological abnormalities. JAMA 287 (2002) 2120-2129
15. Flynn K., and Rimm D. Diagnosis of ASCUS in women over age 50 is less likely to be associated with dysplasia. Diagn Cytopathol 24 (2001) 132-136
16. Dresang L.T. Colposcopy: an evidence-based update. J Am Board Fam Pract 18 (2005) 383-392
17. National Cancer Institute Workshop. The Bethesda System for reporting cervical/vaginal cytologic diagnoses: revised after second National Cancer Institute Workshop (April 29-30,1991). Acta Cytol 37 (1993) 115-124
18. Abati A., Jaffurs W., and Wilder A.M. Squamous atypia in the atrophic cervical vaginal smear: a new look at an old problem. Cancer 84 (1998) 218-225
19. Selvaggi S.M. Atrophic vaginitis versus invasive squamous cell carcinoma on ThinPrep cytology: can the background be reliably distinguished?. Diagn Cytopathol 27 (2002) 362-364
20. Saad R.S., Kanbour-Shakir A., Lu E., Modery J., and Kanbour A. Cytomorphologic analysis and histological correlation of high-grade squamous intraepithelial lesions in postmenopausal women. Diagn Cytopathol 34 (2006) 467-471
21. Jemal A., Tiwari R.C., Murray T., et al. Cancer statistics, 2004. Cancer J Clin 54 (2004) 8-29
22. Menezes G.A., Wakely P.E., Stripe D.M., and Nuovo G.J. Increased incidence of atypical Papanicolaou tests from Thinpreps of postmenopausal women receiving hormone replacement therapy. Cancer Cytopathol 93 (2001) 357-363
23. Smith J.S., Green J., Berrington de Gonzalez A., et al. Cervical cancer and use of hormonal contraceptives: a systematic review. Lancet 361 (2003) 1159-1167
24. Moodley M., Moodley J., Chetty R., and Herrington C.S. The role of steroid contraceptive hormones in the pathogenesis of invasive cervical cancer: a review. Int J Gynecol Cancer 13 (2003) 103-110
25. Johnston E.I., and Logani S. Cytologic diagnosis of atypical squamous cells of undetermined significance inperimenopausal and postmenopausal women: lessons learned from human Papillomavirus DNA testing. Cancer 111 (2007) 160-165
26. Moss S., et al. Effect of testing for human papillomavirus as a triage during screening for cervical cancer: observational before and after study. BMJ 332 (2006) 83-85
27. Saunders N., Anderson D., Gilbert L., and Sharp F. Unsatisfactory colposcopy and the response to orally administered oestrogen: a randomized double blind placebo controlled trial. Br J Obstet Gynaecol 97 (1990) 731-733
28. Milam M.R., Pollock J.W., Nick A.M., Scott T., and Jones III H.W. The effect of hormonal contraception on the adequacy of colposcopic examination of the cervix. Am J Obstet Gynecol 192 (2005) 1368-1369
29. Kim J.J., Wright T.C., and Goldie S.J. Cost-effectiveness of alternative triage strategies for atypical squamous cells of undetermined significance. JAMA 287 (2002) 2382-2390
30. Solomon D., Stoler M., Jeronimo J., Khan M., Castle P., and Schiffman M. Diagnostic utility of endocervical curettage in women undergoing colposcopy for equivocal or low-grade cytologic abnormalities. Obstet Gynecol 110 (2007) 288-295